We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Centene (CNC) Q3 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
The upcoming report from Centene (CNC - Free Report) is expected to reveal quarterly earnings of $1.39 per share, indicating a decline of 30.5% compared to the year-ago period. Analysts forecast revenues of $37.91 billion, representing a decrease of 0.4% year over year.
The consensus EPS estimate for the quarter has been revised 11.3% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Centene metrics that are commonly tracked and forecasted by Wall Street analysts.
The average prediction of analysts places 'Revenues- Premium and service revenues' at $34.64 billion. The estimate indicates a change of -0.9% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Revenues- Premium' of $33.81 billion. The estimate indicates a change of -0.2% from the prior-year quarter.
Analysts forecast 'Revenues- Service' to reach $833.40 million. The estimate points to a change of -24.3% from the year-ago quarter.
It is projected by analysts that the 'Revenues- Premium tax' will reach $3.14 billion. The estimate indicates a change of +2% from the prior-year quarter.
According to the collective judgment of analysts, 'Total Medical Health (Benefits) loss Ratios -Total Ratio (HBR)' should come in at 88.6%. The estimate compares to the year-ago value of 87%.
The consensus estimate for 'Membership Medicaid - High Acuity Medicaid' stands at 1,482.48 thousand. The estimate is in contrast to the year-ago figure of 1.77 million.
Based on the collective assessment of analysts, 'Membership by line of business - Medicaid' should arrive at 13,067.26 thousand. Compared to the current estimate, the company reported 15.24 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'SG&A Expense Ratio' will likely reach 8.7%. The estimate compares to the year-ago value of 8.7%.
Analysts predict that the 'Membership Medicaid - Traditional Medicaid' will reach 11,584.78 thousand. Compared to the current estimate, the company reported 13.47 million in the same quarter of the previous year.
Analysts expect 'Membership by line of business - Medicare PDP' to come in at 6,654.14 thousand. The estimate compares to the year-ago value of 4.54 million.
The consensus among analysts is that 'Membership by line of business - Medicare' will reach 1,113.34 thousand. The estimate is in contrast to the year-ago figure of 1.31 million.
Analysts' assessment points toward 'Membership Commercial - Commercial Group' reaching 421.73 thousand. Compared to the current estimate, the company reported 424.2 thousand in the same quarter of the previous year.
Shares of Centene have experienced a change of -19% in the past month compared to the +2.8% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), CNC is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unveiling Centene (CNC) Q3 Outlook: Wall Street Estimates for Key Metrics
The upcoming report from Centene (CNC - Free Report) is expected to reveal quarterly earnings of $1.39 per share, indicating a decline of 30.5% compared to the year-ago period. Analysts forecast revenues of $37.91 billion, representing a decrease of 0.4% year over year.
The consensus EPS estimate for the quarter has been revised 11.3% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Centene metrics that are commonly tracked and forecasted by Wall Street analysts.
The average prediction of analysts places 'Revenues- Premium and service revenues' at $34.64 billion. The estimate indicates a change of -0.9% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Revenues- Premium' of $33.81 billion. The estimate indicates a change of -0.2% from the prior-year quarter.
Analysts forecast 'Revenues- Service' to reach $833.40 million. The estimate points to a change of -24.3% from the year-ago quarter.
It is projected by analysts that the 'Revenues- Premium tax' will reach $3.14 billion. The estimate indicates a change of +2% from the prior-year quarter.
According to the collective judgment of analysts, 'Total Medical Health (Benefits) loss Ratios -Total Ratio (HBR)' should come in at 88.6%. The estimate compares to the year-ago value of 87%.
The consensus estimate for 'Membership Medicaid - High Acuity Medicaid' stands at 1,482.48 thousand. The estimate is in contrast to the year-ago figure of 1.77 million.
Based on the collective assessment of analysts, 'Membership by line of business - Medicaid' should arrive at 13,067.26 thousand. Compared to the current estimate, the company reported 15.24 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'SG&A Expense Ratio' will likely reach 8.7%. The estimate compares to the year-ago value of 8.7%.
Analysts predict that the 'Membership Medicaid - Traditional Medicaid' will reach 11,584.78 thousand. Compared to the current estimate, the company reported 13.47 million in the same quarter of the previous year.
Analysts expect 'Membership by line of business - Medicare PDP' to come in at 6,654.14 thousand. The estimate compares to the year-ago value of 4.54 million.
The consensus among analysts is that 'Membership by line of business - Medicare' will reach 1,113.34 thousand. The estimate is in contrast to the year-ago figure of 1.31 million.
Analysts' assessment points toward 'Membership Commercial - Commercial Group' reaching 421.73 thousand. Compared to the current estimate, the company reported 424.2 thousand in the same quarter of the previous year.
View all Key Company Metrics for Centene here>>>
Shares of Centene have experienced a change of -19% in the past month compared to the +2.8% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), CNC is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>